Modification of a SARS-CoV-2 spike-RBD targeting nanobody for pH-dependent binding and its chromatographic engineering for purification of WT and variant S-RBDs with mild elution conditions
Xindan Zhang(Xinjiang University), Guangwen Lu(Sichuan University), Guobo Shen(Central South University), Bin He(Guiyang Medical University), Fanli Yang(Sichuan University), Zimin Chen(Sichuan University), Lingling Wang(Shandong University of Traditional Chinese Medicine), H. J. Yang(Ministry of Education of the People's Republic of China), Wei Wang(Sichuan University), Jian Li(Beijing Normal University), Jing Yang(Sun Yat-sen University), Li Yang(Sichuan University), Jiong Li(Sichuan University), Jinliang Yang(Sichuan University), Yu Cao(Sichuan University), Sheng Lin(Guangzhou Medical University), Zhenling Wang(Sichuan University), Qi Zhao(Northwest A&F University), Xin Yuan(Sichuan University), Xiawei Wei(Sichuan University), Liyan Guo(Sichuan University), Pengli Xu(Henan Agricultural University)
Cited by 1
Related Papers
The JAK/STAT signaling pathway: from bench to clinic
|Signal Transduction and Targeted Therapy|2021|2.4k
A new class of membrane-bound chemokine with a CX3C motif
|Nature|1997|2k
Targeting PI3K in cancer: mechanisms and advances in clinical trials
|Molecular Cancer|2019|1.6k
Sirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase
|Science|2011|1.4k
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
|Signal Transduction and Targeted Therapy|2019|1.1k